Washington, Nov 26 (ANI): Scientists from McGill University have come up with an innovative, customised HIV treatment that has proved to be more effective against the virus than the anti-retroviral cocktails currently used.
The new therapy developed by Dr. J-P. Routy of McGill University and Dr. R. S
| Radiation therapy ‘treats pain in patients with advanced cancer’ Washington, Nov 4 (ANI): Scientists from University of Pittsburgh Cancer Institute (UPCI) have pioneered a radiation therapy procedure that could help reduce pain in patients with cancer that has spread to the spine. Lead researcher Dr Dwight E. Heron,... |
| Now virtual nurses for HIV patients! Toronto, Dec 10 (IANS) HIV patients will now have virtual peers or nurses to help them through their treatment. Canada's Montreal University has successfully created these virtual peers to help HIV patients in optimising their treatment. These characters... |
| WHO should revise TB treatment guidelines, say scientists Washington, Sep 15 (ANI): French and American scientists have recommended that the World Health Organization (WHO) must review, and adjust its guidelines for the fight against tuberculosis (TB). TB is a global threat that affects more than 10 million... |
| Non-invasive treatment for major depression Washington, Nov 6 (ANI): Patients suffering from major depression now have a safe, effective, non-drug treatment, thanks to the Transcranial Magnetic Stimulation (TMS) Clinic opened by Rush University Medical Center. TMS therapy is the first FDA-approved,... |
| Major advance in human antibody therapy against deadly Nipah virus Washington, Oct 31 (ANI): A novel antibody treatment may spell the end of the deadly Nipah virus and the related Hendra virus, according to a new study. Nipah and Hendra viruses are found in Pteropid fruit bats (flying foxes) and are characterized by... |
| Short-term radiation therapy works well for breast cancer patients Researchers in Canada have found that an intense three-week course of radiation therapy is just as effective as the standard five-week regimen for women with early-stage breast cancer. In the study, lead researcher Dr. Tim Whelan, a professor... |
